Valuation Adaptive Biotechnologies Corporation
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 28.37 USD | +2.57% |
|
+12.00% | +74.69% |
Company Valuation: Adaptive Biotechnologies Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,960 | 1,093 | 709.4 | 884.7 | 2,479 | 4,528 | - | - |
| Change | - | -72.41% | -35.07% | 24.72% | 180.23% | 82.62% | - | - |
| Enterprise Value (EV) 1 | 3,607 | 594.4 | 653.7 | 795.7 | 2,379 | 4,241 | 4,197 | 4,128 |
| Change | - | -83.52% | 9.97% | 21.72% | 198.96% | 78.26% | -1.03% | -1.65% |
| P/E | -19x | -5.46x | -3.14x | -5.55x | -41.6x | -52.6x | -164x | 2,676x |
| PBR | 6.57x | 2.36x | 2.29x | 4.38x | 11.1x | 34.8x | 42.2x | 34.8x |
| PEG | - | 1.01x | -0.3x | 0.2x | 0.7x | -1.4x | 2.4x | -25x |
| Capitalization / Revenue | 25.7x | 5.9x | 4.17x | 4.94x | 8.95x | 15.4x | 12.6x | 10.2x |
| EV / Revenue | 23.4x | 3.21x | 3.84x | 4.45x | 8.59x | 14.5x | 11.7x | 9.26x |
| EV / EBITDA | -23.8x | -4.89x | -5.62x | -9.9x | 196x | 935x | 92.5x | 50.8x |
| EV / EBIT | -17.3x | -2.97x | -2.88x | -4.9x | -41.6x | -69.9x | -149x | 3,212x |
| EV / FCF | -14.2x | -2.97x | -3.91x | -8.05x | -48.6x | -1,060x | 91.2x | 43.9x |
| FCF Yield | -7.05% | -33.7% | -25.5% | -12.4% | -2.06% | -0.09% | 1.1% | 2.28% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.48 | -1.4 | -1.56 | -1.08 | -0.39 | -0.5396 | -0.1728 | 0.0106 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 154.3 | 185.3 | 170.3 | 179 | 277 | 293.2 | 360.1 | 445.5 |
| EBITDA 1 | -151.7 | -121.6 | -116.4 | -80.37 | 12.15 | 4.535 | 45.39 | 81.26 |
| EBIT 1 | -209 | -200.2 | -227 | -162.5 | -57.12 | -60.66 | -28.09 | 1.285 |
| Net income 1 | -207.3 | -200.2 | -225.2 | -159.5 | -59.5 | -85.03 | -27.23 | 1.512 |
| Net Debt 1 | -353.1 | -498.2 | -55.68 | -89.02 | -100.4 | -287.2 | -330.8 | -400 |
| Reference price 2 | 28.06 | 7.64 | 4.90 | 6.00 | 16.24 | 28.37 | 28.37 | 28.37 |
| Nbr of stocks (in thousands) | 141,132 | 143,012 | 144,773 | 147,579 | 152,665 | 159,596 | - | - |
| Announcement Date | 2/15/22 | 2/14/23 | 2/14/24 | 2/11/25 | 2/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -51.26x | 14.07x | 910.05x | -.--% | 4.41B | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 19.06x | 25.10x | 105.01x | 0.31% | 38.48B | |
| Weighted average by Cap. | 25.66x | 25.10x | 25.94x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ADPT Stock
- Valuation Adaptive Biotechnologies Corporation
Select your edition
All financial news and data tailored to specific country editions
